Long-Term Follow-up of Chronic Phase Chronic Myeloid Leukemia Patients Who Failed Interferon Alpha and Switched to Imatinib

被引：0
|
作者：
Breccia, Massimo [1 ]
Loglisci, Giuseppina [2 ]
Salaroli, Adriano [2 ]
Serrao, Alessandra [2 ]
Zacheo, Irene [2 ]
Latagliata, Roberto [2 ]
Alimena, Giuliana [3 ]
机构：
[1] Univ Roma La Sapienza, Dept Biotechnol & Hematol, Rome, Italy
[2] Univ Roma La Sapienza, Rome, Italy
[3] Univ Rome, Dept Biotechnol & Hematol, Rome, Italy
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3742.3742
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3742
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-term follow-up after stem cell transplantation for chronic myeloid leukemia in 1st chronic phase
    Yeshurun, M
    Guardiola, P
    Devergie, A
    Ades, L
    Ribaud, P
    Esperou, H
    Gluckman, E
    Socié, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S19 - S19
  • [32] LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS-B TREATED WITH ALPHA-INTERFERON
    LAU, D
    KLEINER, DE
    PARK, Y
    VERGALLA, J
    HOOFNAGLE, JH
    HEPATOLOGY, 1995, 22 (04) : 876 - 876
  • [33] Long-term follow-up of patients with chronic hepatitis C after interferon-alpha treatment
    Teuber, G
    Dienes, HP
    zumBuschenfelde, KHM
    Gerken, G
    DIGESTION, 1996, 57 (06) : 464 - 471
  • [34] LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH ALPHA-INTERFERON
    SHINDO, M
    DIBISCEGLIE, AM
    HOOFNAGLE, JH
    HEPATOLOGY, 1992, 15 (06) : 1013 - 1016
  • [35] LONG-TERM BOSUTINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) AFTER PRIOR IMATINIB FAILURE
    Bruemmendorf, T. H.
    Cortes, J. E.
    Khoury, H. J.
    Kantarjian, H. M.
    Kim, D. -W.
    Schafhausen, P.
    Zeremski, M.
    Bardy-Bouxin, N.
    Shapiro, M.
    Leip, E.
    Gambacorti-Passerini, C.
    Lipton, J. H.
    HAEMATOLOGICA, 2015, 100 : 232 - 232
  • [36] Long-term follow-up results of alpha-interferon (alpha-IFN)-based regimens in patients with late chronic phase chronic myelogenous leukemia (CP-CML).
    Sacchi, S
    Kantarjian, H
    OBrien, S
    Keating, M
    Freireich, E
    Talpaz, M
    BLOOD, 1996, 88 (10) : 3531 - 3531
  • [37] Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase
    Moura, Muriel Silva
    Pagnano, Katia B.
    Benevides, Thais
    De Souza, Carmino A., Sr.
    Lorand-Metze, Irene
    Delamain, Marcia T.
    Duarte, Gislaine O.
    Pericole, Fernando V.
    Percout, Priscila
    Dias, Maria
    Duarte, Bruno
    Campos, Paula
    Assuncao, Paola
    Oliveira, Luciene
    Paul, Pamela
    Fernandes, Eliana
    BLOOD, 2013, 122 (21)
  • [38] Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
    Ottmann, Oliver
    Saglio, Giuseppe
    Apperley, Jane F.
    Arthur, Christopher
    Bullorsky, Eduardo
    Charbonnier, Aude
    Dipersio, John F.
    Kantarjian, Hagop
    Khoury, Hanna Jean
    Kim, Dong-Wook
    Healey, Diane
    Strauss, Lewis
    Cortes, Jorge E.
    BLOOD CANCER JOURNAL, 2018, 8
  • [39] Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
    Oliver Ottmann
    Giuseppe Saglio
    Jane F. Apperley
    Christopher Arthur
    Eduardo Bullorsky
    Aude Charbonnier
    John F. Dipersio
    Hagop Kantarjian
    Hanna Jean Khoury
    Dong-Wook Kim
    Diane Healey
    Lewis Strauss
    Jorge E. Cortes
    Blood Cancer Journal, 8
  • [40] Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib
    Kim, Theo D.
    Schwarz, Michaela
    Kreuzer, Karl-Anton
    Kaeda, Jaspal
    Movassaghi, Kamran
    Grille, Peggy
    Daniel, Peter T.
    Doerken, Bernd
    le Coutre, Philipp
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 517 - 520
12345